Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
T ype 1 diabetes (T1D) is one of the most common chronic diseases of childhood with an estimated prevalence of more than 166 000 cases in children younger than 20 years of age in the US in 2010. The rate of new-onset diabetes also is increasing worldwide, with an increased incidence of 3%-5% per year. In 1993 the Diabetes Control and Complications Trial established the benefit of intensive insulin therapy in reducing long-term complications, including retinopathy, nephropathy, and neuropathy. Despite this now longstanding knowledge, vascular complications attributable to hyperglycemia remain a significant issue in the T1D population, even in the young-adult population. Recent evidence from the T1D Exchange clinic registry shows that during childhood mean hemoglobin A1c (HbA1c) remains above the target of 7.5% for all age groups, with a peak of 9.2% in the late teenage years. This evidence points toward the urgent need for better therapeutic interventions to improve glycemic control across the pediatric population. Innovations in diabetes care are being pursued on many fronts, including education, behavioral interventions, pharmaceutical development, beta-cell transplantation, and immunomodulation to prevent autoimmune beta-cell destruction. Although these therapies aim to provide benefit now andmore so in the future, many in the diabetes community believe that the most impactful near-term benefit will be achieved by innovation in the technologies used to manage diabetes. Portable subcutaneous continuous insulin infusion (CSII) pumps first became possible in the early 1970s and achieved improved glycemic control in early studies. Publication of the Diabetes Control and Complications Trial in 1993 demonstrated the importance of strict glycemic control and with it increased interest in the use of technology tominimize hyperglycemia without increasing hypoglycemia, still considered the greatest barrier to tight glucose control. The late 1990s and early 2000s saw rapid expansion in design and availability of CSII systems as research showed improved outcomes with use of this technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274 · cited 1×
“This model is then used to predict the appropriate dosing action for a fixed time interval (eg, 515 minutes), after which time the system is reassessed and the appropriate model selected for the next time interval.(66,67) Fuzzy logic control uses a series of “fuzzy” logical decision rules based on the current glucose…”
MethodMiller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254 · cited 1×
“2% in the late teenage years.(6) This evidence points toward the urgent need for better therapeutic interventions to improve glycemic control across the pediatric population.”
BackgroundSelf-citationEffectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894 · cited 1×
“The combination of patient use of CGM and CSII pump technology with the patient/parent making all decisions in insulin dosing is known as sensor-augmented pump (SAP) therapy.(29)”
MethodThreshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433 · cited 1×
“Publication of the Diabetes Control and Complications Trial in 1993 demonstrated the importance of strict glycemic control and with it increased interest in the use of technology tominimize hyperglycemia without increasing hypoglycemia, still considered the greatest barrier to tight glucose control.(3,8) The late 1990…”
BackgroundLy, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Self-citationFully Integrated Artificial Pancreas in Type 1 Diabetes
Breton, M., Farret, A., Bruttomesso, D., Anderson, S., Magni, L., Patek, S., Dalla Man, C., Place, J., Demartini, S., Del Favero, S., et al. (2012) · Diabetes · doi:10.2337/db11-1445 · Cited by 315
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Cited by
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737
Electrochemical Glucose Sensing: Is There Still Room for Improvement?
Witkowska Nery, E., Kundys, M., Jeleń, P. S., & Jönsson-Niedziółka, M. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03151 · Cited by 292
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Self-citationA clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm
Messer, L. H., Berget, C., & Forlenza, G. P. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0105 · Cited by 100
“Advanced Diabetes Devices Advanced diabetes devices are defined here as systems that combine insulin pump and CGM technology with an algorithm to adjust insulin delivery in response to sensor glucose values in real-time.(4) Examples of advanced diabetes devices include low glucose suspend systems, PLGS systems, and HC…”
BackgroundSelf-citationDevelopment and evaluation of the Flourish Diabetes Programme
Kruger, S., Deacon, E., van Rensburg, E., & Segal, D. (2025) · Health SA Gesondheid · doi:10.4102/hsag.v30i0.2923 · Cited by 1
“While the system automates some aspects of diabetes management, meal boluses still require manual administration (Forlenza, Buckingham & Maahs 2016).”
Metadata
- Authors
- Forlenza, G. P., Buckingham, B., & Maahs, D. M.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 169
- Pages
- 13-20
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2212493618
- Cited by
- 58
- References
- 13
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. https://app.cochat.ai/papers/10.1016/j.jpeds.2015.10.015
- The paper
- Forlenza, G. P., Buckingham, B., & Maahs, D. M. (2016). Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2015.10.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.